Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.3576
+0.0106 (3.05%)
Dec 22, 2025, 4:00 PM EST - Market closed

Vaxart Revenue

Vaxart had revenue of $39.73M in the quarter ending June 30, 2025, with 520.68% growth. This brings the company's revenue in the last twelve months to $80.72M, up 479.58% year-over-year. In the year 2024, Vaxart had annual revenue of $28.70M with 288.94% growth.

Revenue (ttm)
$80.72M
Revenue Growth
+479.58%
P/S Ratio
0.55
Revenue / Employee
$1,411,467
Employees
105
Market Cap
85.67M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202428.70M21.32M288.94%
Dec 31, 20237.38M7.27M6,796.26%
Dec 31, 2022107.00K-785.00K-88.00%
Dec 31, 2021892.00K-3.15M-77.95%
Dec 31, 20204.05M-5.82M-58.97%
Dec 31, 20199.86M5.70M137.12%
Dec 31, 20184.16M-1.68M-28.77%
Dec 31, 20175.84M-3.06M-34.39%
Jun 30, 20178.90M-400.00K-4.30%
Jun 30, 20169.30M-15.30M-62.20%
Jun 30, 201524.60M-44.10M-64.19%
Jun 30, 201468.70M35.10M104.46%
Jun 30, 201333.60M13.20M64.71%
Jun 30, 201220.40M5.56M37.48%
Dec 31, 201114.84M2.34M18.70%
Jun 30, 201112.50M-22.51M-64.29%
Dec 25, 201035.01M24.52M233.73%
Dec 26, 200910.49M--
Dec 27, 2008---
Dec 29, 2007---
Dec 30, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings